Pages that link to "Q37356199"
Jump to navigation
Jump to search
The following pages link to Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug (Q37356199):
Displaying 50 items.
- Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy (Q26745710) (← links)
- Targeting cancer stem cells by using the nanoparticles (Q26783590) (← links)
- siRNA Versus miRNA as Therapeutics for Gene Silencing (Q26786876) (← links)
- Precision targeted therapy of ovarian cancer (Q28078658) (← links)
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target (Q28083115) (← links)
- Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery (Q28085438) (← links)
- Progress and problems with the use of suicide genes for targeted cancer therapy (Q28262370) (← links)
- Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian Cancer (Q29247912) (← links)
- Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy (Q30830508) (← links)
- Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma (Q31132171) (← links)
- Ovarian cancer stem cells: are they real and why are they important? (Q35047699) (← links)
- MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. (Q35089472) (← links)
- Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy. (Q35229094) (← links)
- Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy (Q35284618) (← links)
- Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer (Q35587385) (← links)
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer (Q35832351) (← links)
- Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis (Q35930414) (← links)
- Expression and Function of CD44 in Epithelial Ovarian Carcinoma (Q36409587) (← links)
- CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination (Q36413446) (← links)
- The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma (Q36805567) (← links)
- Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention (Q37672440) (← links)
- The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression. (Q37740526) (← links)
- Targeting hyaluronic acid family for cancer chemoprevention and therapy (Q38235792) (← links)
- Perspectives of CD44 targeting therapies (Q38282790) (← links)
- Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications (Q38292341) (← links)
- The Role of CD44 in Disease Pathophysiology and Targeted Treatment. (Q38466771) (← links)
- CD44 silencing decreases the expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor α in lung cancer: Preliminary findings. (Q38705954) (← links)
- Dendrimer-mediated approaches for the treatment of brain tumor. (Q38755622) (← links)
- Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells (Q38769550) (← links)
- Peptide-Decorated Dendrimers and Their Bioapplications (Q38779839) (← links)
- Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer (Q38787321) (← links)
- Modifying the tumor microenvironment using nanoparticle therapeutics (Q38796320) (← links)
- Dendrimer-based nanocarriers: a versatile platform for drug delivery (Q38820422) (← links)
- Delivery strategies and potential targets for siRNA in major cancer types (Q38853191) (← links)
- LHRH-Targeted Drug Delivery Systems for Cancer Therapy. (Q38980206) (← links)
- Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. (Q41734074) (← links)
- Targeted Delivery of siRNA Therapeutics to Malignant Tumors. (Q47152520) (← links)
- Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer (Q49816432) (← links)
- Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin. (Q52596252) (← links)
- Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel. (Q52880516) (← links)
- Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance. (Q53697399) (← links)
- Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention. (Q55018323) (← links)
- Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells. (Q55657196) (← links)
- Cancer Cell Glycocalyx and Its Significance in Cancer Progression (Q57168005) (← links)
- Upregulation Predicts a Poor Prognosis and Associates with a Possible Mechanism for Paclitaxel Resistance in Ovarian Cancer (Q57296976) (← links)
- A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer (Q89172934) (← links)
- Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells (Q89355308) (← links)
- The Evolving Landscape of Cancer Stem Cells and Ways to Overcome Cancer Heterogeneity (Q90241029) (← links)
- Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting (Q91656739) (← links)
- Ovarian cancer stem cells and targeted therapy (Q91763529) (← links)